Literature DB >> 3106022

Characterization of the content of occluded biliary endoprostheses.

A K Groen, T Out, K Huibregtse, B Delzenne, F J Hoek, G N Tytgat.   

Abstract

In an attempt to establish why biliary endoprostheses clog we analysed the contents of 21 occluded endoprostheses. The major components of the endoprosthesis sludge were protein (25%) and an insoluble residue (20%) which consisted mainly of plant fibers. Compared with bile the material was also rich in unconjugated bilirubin, while the major components of bile--bile acids and lecithin--accounted for only 15%. Although the sludge often contained some cholesterol crystals, no cholesterol gallstones or pigment or mixed stones were found. The material contained bacteria, but not in abundance. Scanning electron microscopy of the walls of clogged endoprostheses revealed adherence of amorphous material, probably protein. SDS-polyacrylamide gel electrophoresis of the protein fraction of the material from different endoprostheses showed a characteristic pattern. The material always contained two major bands of approximately 16 and 13 kDalton, which were not observed in corresponding bile samples. The 16 and 13 kDalton proteins bound most avidly to the endoprosthesis wall. We postulate that the initial phase in the clogging process is adsorption of proteins, after which other materials such as bacteria, fibers from food and unconjugated bilirubin bind to the wall of the endoprosthesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106022     DOI: 10.1055/s-2007-1018235

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  28 in total

1.  The effect of indwelling endoprosthesis on stone size or fragmentation after long-term treatment with biliary stenting for large stones.

Authors:  P Katsinelos; I Galanis; I Pilpilidis; G Paroutoglou; P Tsolkas; B Papaziogas; S Dimiropoulos; E Kamperis; D Katsiba; M Kalomenopoulou; A Papagiannis
Journal:  Surg Endosc       Date:  2003-08-15       Impact factor: 4.584

2.  Endoscopic therapy for biliary obstruction.

Authors:  N Soehendra; K F Binmoeller; H Grimm
Journal:  World J Surg       Date:  1992 Nov-Dec       Impact factor: 3.352

Review 3.  Drug eluting biliary stents to decrease stent failure rates: A review of the literature.

Authors:  Joseph Shatzel; Jisoo Kim; Kartik Sampath; Sharjeel Syed; Jennifer Saad; Zilla H Hussain; Kabir Mody; J Marc Pipas; Stuart Gordon; Timothy Gardner; Richard I Rothstein
Journal:  World J Gastrointest Endosc       Date:  2016-01-25

4.  Covered self-expanding transhepatic biliary stents: clinical pilot study.

Authors:  S A Thurnher; J Lammer; M M Thurnher; F Winkelbauer; O Graf; R Wildling
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Jan-Feb       Impact factor: 2.740

Review 5.  Plastic biliary stent occlusion: factors involved and possible preventive approaches.

Authors:  Gianfranco Donelli; Emilio Guaglianone; Roberta Di Rosa; Fausto Fiocca; Antonio Basoli
Journal:  Clin Med Res       Date:  2007-03

Review 6.  Antireflux biliary stents: are they the solution to stent occlusions?

Authors:  D Nageshwar Reddy; Rupa Banerjee; Ong Wai Choung
Journal:  Curr Gastroenterol Rep       Date:  2006-04

7.  Clogging of biliary endoprostheses: a new perspective.

Authors:  P P Coene; A K Groen; J Cheng; M M Out; G N Tytgat; K Huibregtse
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

Review 8.  Endoscopic stenting for palliation of malignant biliary obstruction. A review of progress in the last 15 years.

Authors:  J J Sung; S C Chung
Journal:  Dig Dis Sci       Date:  1995-06       Impact factor: 3.199

9.  Metallic stents for the treatment of biliary obstruction: a report of 100 cases.

Authors:  H Coons
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Nov-Dec       Impact factor: 2.740

10.  Malignant biliary obstruction: treatment with self-expandable stainless steel endoprosthesis.

Authors:  E K Salomonowitz; A Adam; F Antonucci; G Stuckmann; C L Zollikofer
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Nov-Dec       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.